Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Monocyte-to-macrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory environment within the vessel wall. In this study, we investigated the molecular mechanisms responsible for monocyte-to-macrophage differentiation and, subsequently, the effect of metformin in regressing angiotensin II (Ang-II)-mediated atheromatous plaque formation in ApoE−/− mice. AMPK activity was dose and time dependently downregulated during phorbol myristate acetate (PMA)-induced monocyte-to-macrophage differentiation, which was accompanied by an upregulation of proinflammatory cytokine production. Of note, AMPK activators metformin and AICAR significantly attenuated PMA-induced monocyte-to-macrophage differentiation and proinflammatory cytokine production. However, inhibition of AMPK activity alone by compound C was ineffective in promoting monocyte-to-macrophage differentiation in the absence of PMA. On the other hand, inhibition of c-Jun N-terminal kinase activity inhibited PMA-induced inflammation but not differentiation, suggesting that inflammation and differentiation are independent events. In contrast, inhibition of STAT3 activity inhibited both inflammation and monocyte-to-macrophage differentiation. By decreasing STAT3 phosphorylation, metformin and AICAR through increased AMPK activation caused inhibition of monocyte-to-macrophage differentiation. Metformin attenuated Ang-II–induced atheromatous plaque formation and aortic aneurysm in ApoE−/− mice partly by reducing monocyte infiltration. We conclude that the AMPK-STAT3 axis plays a pivotal role in regulating monocyte-to-macrophage differentiation and that by decreasing STAT3 phosphorylation through increased AMPK activity, AMPK activators inhibit monocyte-to-macrophage differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A working model of metformin’s anti-inflammatory properties also suggests that metformin, in an AMPK-dependent inhibition of STAT3, prevents the differentiation of monocytes to macrophages”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Vasamsetti et al. 2015
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274 · cited 1×
“AMPK-mediated signaling events are downregulated by lipopolysaccharides (LPSs), free fatty acids, high-fat diets, and lipid infusion in macrophages and endothelial cells (12,13).”
BackgroundRetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Earlier studies showed that the pleiotropic effects of metformin are partly mediated by the activation of AMPK (7,8).”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 2×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669 · cited 3×
“a diverse repertoire of inflammatory mediators (2).”
BackgroundThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182 · cited 3×
“Substantial evidence implicates that macrophages are abundantly present at all stages of atherosclerotic disease process (1).”
InfluentialPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637 · cited 1×
“AMPK activity in the blood is predominantly located in monocytes and lymphocytes as the 1a isoform (25), and a reduction in AMPK activity is associated with various pathophysiological effects (26).”
Background
Cited by
Items 201–300 of 431
Kewcharoenwong, C., Prabowo, S. A., Bancroft, G. J., Fletcher, H. A., & Lertmemongkolchai, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02109 · Cited by 26
“Moreover, metformin was observed to inhibit macrophage differentiation via AMPK-mediated inhibition of STAT3 activation and to inhibit TNF-α and MCP-1 production (66).”
BackgroundHu, D., Li, Z., Zhu, Y.-T., & Li, C. (2020) · Aging · doi:10.18632/aging.202392 · Cited by 26
Triclosan induces ROS‑dependent cell death and autophagy in A375 melanoma cells
Jin, J., Chen, N., Pan, H., Xie, W., Xu, H., Lei, S., Guo, Z., Ding, R., He, Y., & Gao, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11934 · Cited by 25
“It has been previously reported that a cross‑talk occurs between AMPK and STAT3 (25,26), thus the present study investigated whether this cross‑talk exists during triclosan‑induced melanoma cell death.”
BackgroundInfluentialUncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture
Bornfeldt, K. (2015) · Diabetes · doi:10.2337/db14-1963 · Cited by 24
Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice
Kunath, A., Unosson, J., Friederich‐Persson, M., Bjarnegård, N., Becirovic‐Agic, M., Björck, M., Mani, K., Wanhainen, A., & Wågsäter, D. (2021) · JVS Vascular Science · doi:10.1016/j.jvssci.2020.11.031 · Cited by 24
“Metformin normalized vascular function, partly in perivascular adipose tissue, inhibited increases in mRNA expression of osteopontin (SPP1) and MMP12(genes involved in aortic aneurysms), and mRNA expression of Gpnmb-and Clec7a-encoding glycoproteins,which are expressed by various leukocytes.”
InfluentialSun, Z., Li, J., Luo, G., Liu, W., He, Y., Wang, F., Qian, Y., & Fan, C. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174386 · Cited by 24
Su, Z., Guo, J., & Gu, Y. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221120423 · Cited by 24
Zhao, Y., Zhao, Y., Tian, Y., & Zhou, Y. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11573 · Cited by 23
“Previous studies have suggested that metformin inhibits the process of atherosclerosis via the AMPK‐PDZ and LIM Domain 5 pathway in diabetic ApoE‐/‐ male mice (26) and reduces the induction of inflammation as demonstrated by the downregulation of the NLRP3 inflam‐ masome (25,32).”
BackgroundPulipaka, S., Chempon, H., Singuru, G., Sahoo, S., Shaikh, A., Kumari, S., Thennati, R., & Kotamraju, S. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111931 · Cited by 23
Self-citationTang, T., Duan, Z., Xu, J., Liang, J., Zhang, S., Zhang, H., Zhang, X., & Wang, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8211 · Cited by 23
“Furthermore, inhibition of STAT3 activation may be a potential therapeutic target in the treatment of atherosclerosis (38).”
Day, E. A., Townsend, L. K., Rehal, S., Batchuluun, B., Wang, D., Morrow, M. R., Lu, R., Lundenberg, L., Lu, J. H., Desjardins, E. M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108269 · Cited by 22
Sciannimanico, S. M., Grimaldi, F., Vescini, F., Pergola, G. D., Iacoviello, M., Licchelli, B., Guastamacchia, E., Giagulli, V. A., & Triggiani, V. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190507125847 · Cited by 22
Timmons, J. G., Greenlaw, N., Boyle, J. G., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Tillin, T., HRAMIAK, I. M., Hughes, A. D., Jenkins, A. J., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14350 · Cited by 22
Research progress of metformin in the treatment of liver fibrosis
Zhang, A., Qian, F., Li, Y., Li, B., Yang, F., Hu, C., Sun, W., & Huang, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109738 · Cited by 22
Zhu, Q., Li, H., Xie, X., Chen, X., Kosuru, R., Li, S., Lian, Q., Cheung, C. W., Irwin, M. G., Ge, R., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4253457 · Cited by 22
“Furthermore, pharmacological activation of AMPK can inhibit STAT3 activation and consequently inhibit monocyte-to-macrophage differentiation and attenuate angiotensin-II-induced atheromatous plaque formation [36].”
BackgroundLi, Y.-K., Zheng, X.-Y., Guo, J., Samura, M., Ge, Y.-B., Zhao, S., Li, G., Chen, X.-F., Shoji, T., Ikezoe, T., et al. (2023) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.122.028081 · Cited by 18
Suzuki, H., Hasegawa, S., Fushimi, S., Tagami, K., Nishikawa, M., Kondo, Y., & Yasuda, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-93647-5 · Cited by 196
“…been reported to be essential for Foxp3 downregulation and decreased Treg generation 45 . mTOR is one of the downstream targets of AMPK and metformin is known to activate AMPK, leading to downregulation of mTORC1 and STAT3 activity, decreased glycolysis, and increased oxidative phosphorylation 46 .”
Teixeira, A. A. D. S., de Souza, C. O., Biondo, L. A., Silveira, L. S., de Lima, E. A., Batatinha, H., Araujo, A. P., Alves, M. J., Hirabara, S. M., Curi, R., et al. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0443-7 · Cited by 21
“2014), (2) impairing monocyte–macrophage differentiation (Vasamsetti et al. 2015) and (3) increasing M2 (anti-inflammatory) macrophages activation (Chen et al.”
BackgroundNjau, F., & Haller, H. G. (2021) · Antioxidants · doi:10.3390/antiox10111798 · Cited by 21
“Overall, these findings agree well with previous studies where antioxidants inhibited monocyte-to-macrophage differentiation and associated inflammation [73,76].”
ResultChristensen, M. S., Nørgård, M. Ø., Jensen, M. S., Møller, B. K., & Nørregaard, R. (2019) · Physiological Reports · doi:10.14814/phy2.14141 · Cited by 21
“Metformin has the ability to inhibit the maturation of monocytes through STAT3 inhibition (Vasamsetti et al. 2015), which also might explain the findings in our study.”
ResultHardie, D. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00073-5 · Cited by 21
Yang, Q., Ma, Q., Xu, J., Liu, Z., Zou, J., Shen, J., Zhou, Y., Da, Q., Mao, X., Lu, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611354 · Cited by 20
“It has been reported that metformin or AICAR attenuates Ang II-induced atheromatous plaque formation and protects against hyperglycemia-induced atherosclerosis (Li et al., 2010; Vasamsetti et al., 2015; Wang et al., 2017) and also reduces insulin resistance (Yang et al.”
BackgroundMetformin in gestational diabetes: physiological actions and clinical applications
Mason, T., Alesi, S., Fernando, M., Vanky, E., Teede, H. J., & Mousa, A. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01049-w · Cited by 20
“Together, these functions of metformin prevent translocation and expression of inflammatory genes, downregulate inflammatory mediators and suppress inflammasome activity to promote broad immunomodulatory effects that are beneficial for overall metabolic and angiogenic function 66 .”
Yang, X., Yang, T., Li, J., Yang, R., Qi, S., Zhao, Y., Li, L., Li, J., Zhang, X., Yang, K., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4084 · Cited by 20
“Notably, previous investigations have shown that metformin suppresses inflammatory responses and monocyte-to-macrophage differentiation through activation of the AMP-activated protein kinase signaling pathway (34).”
BackgroundZhang, N., Zhang, Y., You, S., Tian, Y., Lu, S., Cao, L., & Sun, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39843 · Cited by 20
Chen, H., Pan, J., Zhang, L., Chen, L., Qi, H., Zhong, M., Shi, X., Du, J., & Li, Q. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.025 · Cited by 20
Metformin—mechanisms of its glycemia-reducing effect
Drewe, J., Foretz, M., & Krähenbühl, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100106 · Cited by 19
Functional significance of DNA methylation: epigenetic insights into Sjögren’s syndrome
Wang, Y., Riaz, F., Wang, W., Pu, J., Liang, Y., Wu, Z., Pan, S., Song, J., Yang, L., Zhang, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1289492 · Cited by 20
Langness, S. M., Costantini, T. W., Morishita, K., Eliceiri, B. P., & Coimbra, R. S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168322 · Cited by 19
STAT3–CyPA signaling pathway in endothelial cell apoptosis
Xie, Y., Li, X., & Ge, J. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109413 · Cited by 19
Ke, R., Liu, L., Zhu, Y., Li, S., Xie, X., Li, F., Song, Y., Yang, L., Gao, L., & Li, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060844 · Cited by 19
“AMPK is also found to be activated by several chemical compounds [10,11] and signaling pathways [12] independent of energy imbalance.”
BackgroundRen, C., Tazawa, K., Kawashima, N., Ohshima, R., Okada, Y., Wang, S., Yu, Z., Han, P., Ohsugi, Y., Katagiri, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643676 · Cited by 18
Association Between Metformin and Abdominal Aortic Aneurysm: A Meta-Analysis
Niu, W., Shao, J., Yu, B., Liu, G., Wang, R., Dong, H., Che, H., & Li, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.908747 · Cited by 18
Liu, D., Song, Y., Song, T., Lin, L., Zhang, L., Yang, Q., Niu, X., Liang, D., Yin, J., Yang, W., et al. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/9645789 · Cited by 18
“AMPK activation can reduce oxidative stress, promote autophagy, and play an anti-inflammatory role by delaying endothelial cell senescence and inhibiting the progression of atherosclerosis [16].”
BackgroundLee, E. Y., Kim, J., Lee, S., Lee, S. H., Park, Y. M., Oh, H. Y., Yeom, J., Ahn, H.-S., Yoo, H. J., Kim, B. S., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.10.036 · Cited by 18
Komaru, Y., Takeuchi, T., Suzuki, L., Asano, T., & Urayama, K. Y. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107511 · Cited by 18
Association of Metformin and Abdominal Aortic Aneurysm Repair Outcomes
Turowicz, A., Kobecki, J., Laskowska, A., Wojciechowski, J., Świątkowski, F., & Chabowski, M. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.02.048 · Cited by 18
Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
Picatoste, B., Cerro-Pardo, I., Blanco‐Colio, L. M., & Martín-Ventura, J. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1112430 · Cited by 18
Pham, T., Bak, Y., Oh, J., Hong, J.-G., Lee, S., Hong, J. T., & Yoon, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081949 · Cited by 18
Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis
Chen, X., Dong, Y., Yu, Y., Jiang, M., Bu, W., Li, P., Sun, Z., & Dong, D. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16190 · Cited by 17
“AMPK activation inhibits STAT3 (Vasamsetti et al., 2015) and STAT3-mediated signalling drives lung fibroblast activation and differentiation (Guan et al., 2016; Shieh et al., 2019; Shin et al., 2021).”
BackgroundGannarapu, M. R., Vasamsetti, S. B., Punna, N., Kotamraju, S., & Narsaiah, B. (2015) · MedChemComm · doi:10.1039/c5md00171d · Cited by 17
Self-citationMetformin Triggers Apoptosis and Induction of the G0/G1 Switch 2 Gene in Macrophages
Hu, X., Luo, H., Dou, C., Chen, X., Huang, Y., Wang, L., Xue, S., Sun, Z., Chen, S., Xu, Q., et al. (2021) · Genes · doi:10.3390/genes12091437 · Cited by 17
“STAT3 inhibited the phorbol myristate acetate (PMA)-induced macrophage activation, but this inhibition was removed by metformin-induced AMPK activation [17,18].”
BackgroundMethodArefin, A., & Gage, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054785 · Cited by 17
Li, Y., Han, B., Li, F., Yu, J.-W., Dong, Z., Niu, G., Qing, Y., Li, J., Wei, M., & Zhu, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153659 · Cited by 17
Zhang, Y., Li, Y., Dai, X., Lin, H., & Ma, L. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01101-1 · Cited by 16
Elwany, N. E., Abdelhamid, A. M., Mohamed, N. M., Khalil, S. S., Orabi, E. E., & Abdelfattah, A. M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110654 · Cited by 16
Multi-faceted roles of C1q/TNF-related proteins family in atherosclerosis
Guo, S., Mao, X., & Liu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1253433 · Cited by 16
From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin
Campagnoli, L. I. M., Varesi, A., Fahmideh, F., Hakimizad, R., Petkovic, P., Barbieri, A., Marchesi, N., & Pascale, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199748 · Cited by 16
“…models have shown that metformin attenuates atheromatous plaque formation, suppresses atherogenesis, improves autophagy-mediated cholesterol efflux in vascular smooth muscle cells-derived foam cells (a significant component of atherosclerotic lesions), and reduces glucose production [187–190].”
Ramachandran, S., Anandan, V., Kutty, V. R., Mullasari, A. S., Pillai, M. R., & Kartha, C. S. (2018) · Clinical Science · doi:10.1042/cs20171523 · Cited by 16
Metformin promotes susceptibility to experimental Leishmania braziliensis infection
Lima, F. R., Ferreira, L. D. M., Malta, T. A., Bonyek-Silva, Í., Santos, R. L., Tavares, N. M., Filho, E. M. D. C., & Arruda, S. M. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200272 · Cited by 16
“(10,11) Antidiabetic drug-induced effects include 5’ AMP-activated protein kinase (AMPK) activation, signal transducer and activator of transcription 3 (STAT3) inhibition, and the increased production of mitochondrial reactive oxygen species (ROS).(12,13) Although described in other contexts, little is known about the…”
BackgroundElzahhar, P. A., Alaaeddine, R. A., Nassra, R. A., Ismail, A. E., Labib, H. F., Temraz, M. G., Belal, A. S. F., & EL‐Yazbi, A. F. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1887169 · Cited by 16
Li, Y., Tan, Y., Li, X., Chen, X., Wang, L., Zhang, L., Xu, S., Huang, K., Shu, W., Liang, H., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01227-7 · Cited by 16
“Indeed, several studies have indicated that the STAT3 pathway mediates M1/M2 macrophage polarization during the development of cancer and other diseases [42, 43].”
BackgroundLiu, C., Du, H., Wang, Y., Gong, N., Qi, W., Zhou, X., & Shi, L. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.09.014 · Cited by 15
IMM-H007 improves heart function via reducing cardiac fibrosis
Ge, W., Zhang, W., Gao, R., Li, B., Zhu, H., & Wang, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172442 · Cited by 15
Singh, A., & Sen, P. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158981 · Cited by 15
Mandić, M., Misirkic-Marjanovic, M., Vucicevic, L. M., Jovanović, M., Bošnjak, M., Perović, V., Ristic, B. Z., Ćirić, D., Harhaji-Trajkovic, L. M., & Trajković, V. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120481 · Cited by 15
Xu, B., Li, G., Li, Y.-K., Deng, H., Cabot, A., Guo, J., Samura, M., Zheng, X.-Y., Chen, T., Zhao, S., et al. (2023) · JVS: Vascular Science · doi:10.1016/j.jvssci.2023.100102 · Cited by 11
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer
Conza, D., Mirra, P., Fiory, F., Insabato, L., Nicolò, A., Bèguinot, F., & Ulianich, L. (2023) · Cells · doi:10.3390/cells12172182 · Cited by 15
Kataoka, Y., Nicholls, S. J., Andrews, J., Uno, K., Kapadia, S. R., Tuzcu, E. M., Nissen, S. E., & Puri, R. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-21-346 · Cited by 14
“Cell and animal studies have demonstrated that metformin favorably modulates secretion of proinflammatory cytokines and AMP-activated kinase (AMPK) implicated in atherogenesis (4-6).”
BackgroundYang, P., Wu, Q., Sun, L., Fang, P., Liu, L., Ji, Y. H., Park, J., Qin, X., Yang, X., & Wang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809208 · Cited by 14
Leukocyte-Specific Morrbid Promotes Leukocyte Differentiation and Atherogenesis
Xiang, D., Jiang, L., Yuan, Q., Yu, Y., Liu, R.-M., Chen, M., Kuai, Z., Zhang, W., Yang, F., Wu, T., et al. (2023) · Research · doi:10.34133/research.0187 · Cited by 14
Association of metformin use with abdominal aortic aneurysm: A systematic review and meta-analysis
Dewangga, R., Winston, K., Ilhami, L. G., Indriani, S., Taofan, T., & Adiarto, S. (2024) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/02184923231225794 · Cited by 14
“13,16,26 Diabetes itself has also been reported to be protective against AAA.”
BackgroundWang, S. K., Green, L. A., Gutwein, A. R., Kenyon, B., Motaganahalli, R. L., Fajardo, A. C., Gupta, A., & Murphy, M. P. (2018) · Vascular · doi:10.1177/1708538118777657 · Cited by 14
Bibliometric analysis of metformin as an immunomodulator (2013–2024)
Zhou, T., Yu, Y., Li, L., Liu, X., Xiang, Q., & Yu, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1526481 · Cited by 13
LKB1 Regulates Vascular Macrophage Functions in Atherosclerosis
Wang, X., Liang, Z., Xiang, H., Li, Y., Chen, S., & Lü, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.810224 · Cited by 13
“For example, metformin, an important LKB1/AMPK activator, has been found to improve atherosclerosis (Vasamsetti et al., 2015; Ramachandran et al., 2018).”
BackgroundBalkrishna, A., Gohel, V., Pathak, N., Tomer, M., Rawat, M., Dev, R., & Varshney, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064532 · Cited by 13
“Furthermore, the activation of various inflammatory signaling networks initiates the monocyte to macrophage differentiation (28).”
BackgroundMetformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
Alfaraidi, H., & Samaan, M. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1072879 · Cited by 13
“It also affects the proportion of white blood cells by reducing the ratio of neutrophils to lymphocytes (93) and inhib i t s the d i ff e rent ia t ion of monocytes to macrophages (95).”
BackgroundJang, H., Ojha, U., Jeong, J.-H., Park, K., Lee, S. Y., & Lee, Y. M. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01454-1 · Cited by 13
Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment
Qiao, Z., Zhao, J., Yuan, J., Qin, Y., Zhu, Z., Liu, J., & Sun, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0168 · Cited by 13
“Subsequently, metformin was shown to activate AMPK and disrupt STAT3 phosphorylation, thereby interfering with the inflammatory induction pathway [80].”
Phasic change and apoptosis regulation of JAK2/STAT3 pathway in a type 2 diabetic rat model.
Gao, H., Wu, D., Zhang, E., Liang, T., Meng, X., Chen, L., & Wu, Y. (2019) · Europe PMC (PubMed Central) · Cited by 13
Liu, A., Li, K., Xu, L., Si, M., Teng, G., Li, G., Xue, J., Liang, S., & Song, W. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00761-w · Cited by 13
Chew, G. M., Padua, A. J., Chow, D. C., Souza, S. A., Clements, D. M., Corley, M. J., Pang, A. P. S., Alejandria, M. M., Gerschenson, M., Shikuma, C. M., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0172 · Cited by 13
El-Abasy, H. M., Elsaid, M. E. A., El-Kader, E. M. A., & Shehatou, G. S. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123115 · Cited by 12
Heo, E. Y., Kim, E., Jang, E. J., & Lee, C. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01667-4 · Cited by 12
Yen, F., Wei, J. C., Yip, H., Hsu, C., & Hwu, C. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28278 · Cited by 12
“(2) By suppressing signal transducer and activator of transcription‐3, metformin can inhibit monocyte‐to‐ macrophage differentiation, improve autophagy, and restrict viral multiplication.(20,21) (3) Metformin can activate AMPK and suppress the mammalian target of rapamycin to improve T cell differentiation and cell‐me…”
BackgroundPatel, R., Hall, S., Lanford, H., Ward, N., Grespin, R., Figueroa, M., Mattia, V., Xiong, Y., Mukherjee, R., Jones, J. A., et al. (2023) · Vascular and Endovascular Surgery · doi:10.1177/15385744231152961 · Cited by 9
Oleoylethanolamide alleviates macrophage formation via AMPK/PPARα/STAT3 pathway
Zhao, Y., Lu, Y., Lu, P., Huang, X., Zhang, G., Chen, B., Ren, J., Zhou, Y., Yang, L., Peng, L., et al. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.06.006 · Cited by 12
Metformin adherence and the risk of cardiovascular disease: a population-based cohort study
Yu, S.-F., Hong, C., Chen, W., Chan, L., & Chien, L. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231163115 · Cited by 12
Chen, Y., Su, X., Qin, Q., Yu, Y., Jia, M., Kong, L., Zhang, H., & Li, H. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.106613 · Cited by 12
Yoon, J. P., Park, S., Kim, D., Lee, H. J., Jin, P. E. J., Shim, B.-J., Kim, J. S., & Chung, S. W. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04163-z · Cited by 11
Nakashima, M., Suga, N., Ikeda, Y., Yoshikawa, S., & Matsuda, S. (2024) · Biomolecules · doi:10.3390/biom14020207 · Cited by 11
“The blockade of AMPK signaling could considerably influence the efficiency of metformin for the type-2 diabetes mellitus and/or atherosclerosis [90,91].”
BackgroundThe antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice
Liu, K., Wang, Z.-Y., Ying, Y.-T., Wei, R., Dong, D., & Sun, Z. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116205 · Cited by 11
Targeting the lung tumor microenvironment by phytochemicals and their nanoformulations
Rab, S. O., Altalbawy, F. M. A., Chandra, M., Ariffin, I. A., Kaur, P., Rathore, G., Rizaev, J. A., Aloraibi, F., Najeeb, M. A., Abdulhussain, M. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155679 · Cited by 11
Mechanisms of Action of Metformin
Mahmood, S. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99189 · Cited by 11
Augusto, P. S. D. A., Matsui, T. C., Braga, A. V., Rodrigues, F. F., Morais, M. Í., Dutra, M. M. G. B., Batista, C. R. Á., Melo, I. S. F., Costa, S. O. A. M., Bertollo, C. M., et al. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00899-4 · Cited by 11
Balkrishna, A., Mulay, V. P., Verma, S., Srivastava, J., Lochab, S., & Varshney, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.889335 · Cited by 11
Lakshmi, P. K., Kumar, S., Pawar, S., Kuriakose, B. B., Sudheesh, M. S., & Pawar, R. S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104925 · Cited by 11
Allin, K. H., Jensen, C. B., Jacobsen, R. K., & Jess, T. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01896-2 · Cited by 10
Helk, O., Dekeryte, R., Thompson, D., Kamli-Salino, S., Philip, S., Wilson, H. M., Mody, N., & Delibegović, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04598-2 · Cited by 10
Metabolic Adaptations and Functional Activity of Macrophages in Homeostasis and Inflammation
Yurakova, T. R., Gorshkova, E. A., Nosenko, M. A., & Drutskaya, M. S. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050043 · Cited by 10
Meng, Q., Liu, H., Wu, H., Ding, S., Tang, C., Xin-yin, F., Fang, X., Xu, Y., Chen, B., Xie, Y., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3242015 · Cited by 10
Wang, Y., Su, W., Li, Y., Yuan, J., Yao, M., Su, X., & Wang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935545 · Cited by 10
“Metformin inhibits monocyte-to-macrophage differentiation through AMPK-mediated STAT3 activation, thereby reducing AS plaque formation (49).”
BackgroundMiR-199a-3p Restrains Foaming and Inflammation by Regulating RUNX1 in Macrophages
Liu, M., Cao, Y., Hu, Y., Zhang, Z., Ji, S., Shi, L., & Tao, G. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00484-2 · Cited by 9
“STAT3 participates in regulating monocyte-to-macrophage differentiation, and inhibition of STAT3 activity suppresses both inflammation and monocyte-to-macrophage differentiation [48].”
BackgroundAbdominal aortic aneurysm: a review on the role of oral antidiabetic drugs
Ribeiro-Silva, M., Oliveira‐Pinto, J., & Mansilha, A. (2020) · International Angiology · doi:10.23736/s0392-9590.20.04362-x · Cited by 9
Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients
Sakellakis, M. (2023) · Chemotherapy · doi:10.1159/000531606 · Cited by 9
“Controversy exists over whether metformin-mediated STAT3 inhibition is actually another result of AMPK activation [29].”
BackgroundKaur, K. K., Allahbadia, G. N., & Singh, M. (2021) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2021.08.00216 · Cited by 9
Independent and Combined Impacts of Obesity and Aging on Chronic Kidney Disease
Ma, Y., Xu, C., Shen, Y., Cheng, Y., & Zhao, W. (2025) · Obesity Reviews · doi:10.1111/obr.70023 · Cited by 8
Possible role of metformin as an antidepressant in diabetes
Pedreáñez, A. B., Carrero, Y. N., Vargas, R., Hernández-Fonseca, J. P., & Mosquera-Sulbarán, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.228 · Cited by 8
Pharmacological therapy targeting the immune response in atherosclerosis
Wu, Y., Xu, Y., & Xu, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112974 · Cited by 8
Almohaimeed, G. M., Alonazi, A. S., Alshammari, T. K., Dayel, A. F. B., Alghibiwi, H. K., Alamin, M. A., Almotairi, A. R., Aldawsari, N. A., Alkhelb, D. A., Al‐Rasheed, N. M., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114530 · Cited by 8
Metadata
- Authors
- Vasamsetti, S. B., Karnewar, S., Kanugula, A. K., Thatipalli, A. R., Kumar, J. M., & Kotamraju, S.
- Affiliations
- Indian Institute of Chemical Technology (IN)
- Centre for Cellular and Molecular Biology (IN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-12-31
- Volume
- 64
- Issue
- 6
- Pages
- 2028-2041
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2031565266
- Cited by
- 397
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 42 · 2022: 38 · 2021: 63 · 2020: 45 · 2019: 35 · 2018: 37 · 2017: 25 · 2016: 25 · 2015: 12
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board (F.NO.SR/SO/HS-110/2008)
- Council for Scientific and Industrial Research (EpiHeD-BSC-0118, SMiLE-CSC-0111)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metformin, monocyte-to-macrophage differentiation, AMPK, STAT3 phosphorylation, atherosclerosis, angiotensin II, inflammatory cytokines, c-Jun N-terminal kinase, aortic aneurysm, ApoE-deficient mice, AICAR, macrophage polarization, inflammation
- MeSH terms
- Animals, Apolipoproteins E, Cell Differentiation, Macrophages, Male, Metformin, Monocytes, Polymethacrylic Acids, Mice, Knockout, Atherosclerosis, STAT3 Transcription Factor, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.